Clinical Trial Update: A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma [Phase 2]

View source ↗

Summary

This Phase II study evaluating temozolomide in combination with O6-benzylguanine for temozolomide-resistant anaplastic glioma was terminated, including glioma s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioma
• Oligoastrocytoma
• Oligodendroglioma

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)
• Temodar (Temozolomide)

Snippet

Sponsor: Keryx / AOI Pharmaceuticals, Inc. | Conditions: Glioma, Astrocytoma | Phase 2 | Status: TERMINATED